How to Report SAE in Clinical Trials

Ensuring participant safety in clinical trials is a top priority. Sponsors, investigators, and regulatory bodies work together to monitor and report adverse events, especially serious ones that may jeopardize participants' well-being.

Wearable technology has become increasingly popular in clinical trials, offering real-time, continuous data collection. However, integrating wearables into safety reporting processes can be complex. Understanding what constitutes a Serious Adverse Event (SAE) and how to report it when using wearables is vital to maintaining compliance and protecting participants.

What Are Serious Adverse Events in Clinical Trials?

Serious Adverse Events (SAEs) refer to critical medical incidents that affect participants and require immediate attention and reporting. SAEs are categorized based on specific criteria: results in death, life-threatening risk, hospitalization, long-term disability, or congenital abnormalities.

In wearable technology trials, SAEs may be flagged through abnormal device readings or alerts. Investigators must assess these alerts to determine if they qualify as SAEs, following predefined protocols. Accurate procedures are crucial for leveraging wearables to enhance data collection while upholding safety standards.

Why Is SAE Reporting Critical in Wearable-Based Trials?

How to Report SAEs in Wearable Clinical Trials

1. Establish Clear SAE Definitions and Reporting Protocols

Develop trial-specific protocols that define SAEs, reporting responsibilities, timelines, and procedures. This proactive approach ensures readiness and prioritizes participant well-being.

1.1 Define SAEs for Your Trial

Understand criteria set by regulatory authorities like the FDA and EMA. Evaluate your study population to identify potential SAEs unique to your trial and develop unambiguous definitions in your protocol.

1.2 Assign Reporting Responsibilities

Designate specific roles (investigators, coordinators, monitors) for identification and reporting. Assign team members to regularly review wearable data and escalate findings appropriately.

1.3 Establish Reporting Timelines

Specify the timeframe (typically 24 hours of awareness). Reporting timelines must comply with requirements (e.g., 7 days for fatal/life-threatening events, 15 days for others).

1.4 Document Procedures & Train Staff

Develop SOPs for interpreting wearable data and create standardized reporting forms. Provide comprehensive training and resources to ensure staff proficiency throughout the trial.

2. Monitor Wearable Data for Potential SAEs

Wearable technology enables early detection. Establish data review protocols and leverage platforms with automated alerts for abnormal readings (e.g., heart rate irregularities).

Set customizable thresholds based on your study population to reduce false alarms and integrate data seamlessly with safety monitoring systems to minimize delays.

3. Assess Severity, Relatedness, and Expectedness

When a potential SAE is identified, investigators must determine:

• Severity: Use standardized grading scales like the Common Terminology Criteria for Adverse Events (CTCAE).
• Relatedness: Evaluate timing relative to intervention and investigate other potential causes (comorbidities, medications).
• Expectedness: Consult the investigator brochure to determine if the event is consistent with known safety profiles.

In wearable trials, real-world data establishment of baselines provides valuable context for these assessments.

4. Document and Report SAEs to Sponsors

Complete SAE report forms with detailed demographics, medical history, and device readings. Submit to sponsors within specified windows (usually 24h) and confirm receipt.

5. Notify IRBs and Regulatory Authorities

Investigators must inform IRBs within 5-10 business days. Reports should include event summaries, relatedness assessments, and supporting wearable device data. IRBs ensure appropriate steps are taken to protect participant safety.

6. Perform Ongoing Safety Evaluations

Establish systematic reviews of data to identify emerging signals. Re-assess reported events as new data becomes available and collaborate with Data Safety Monitoring Boards (DSMBs) to maintain independent oversight.

7. Implement Corrective Actions

For unexpected related events, develop a Corrective Action Plan (CAP). Conduct root cause analysis, implement mitigation strategies (dose adjustments, protocol changes), and monitor effectiveness via real-time wearable feedback.

8. Maintain Detailed SAE Documentation

Create dedicated files for each SAE including initial reports, communications, CAPs, and pertinent medical records. Store documentation in centralized, access-controlled, 21 CFR Part 11-compliant systems.

Final Thoughts

Effective SAE reporting safeguards participant safety and upholds research integrity. Establishing clear protocols and leveraging technology allows researchers to utilize wearables effectively.

Reputable Health's platform can streamline your SAE reporting process, ensuring compliance and efficiency.